EFFICIENT NUCLEAR DELIVERY VECTOR FOR MACROMOLECULES
EFFICIENT NUCLEAR DELIVERY VECTOR FOR MACROMOLECULES
批准号:
6021317
负责人:
ROBERT A DUBIN
金额:
$9.31万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-08-10 至 2000-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The ability to efficiently introduce functional, exogenous macromolecules into living cells is severely restricted by the plasma membrane. The development of vectors to overcome this barrier, such as disabled virus, cationic lipids, and direct injection, currently offer the potential for advances in therapeutic intervention and basic genetic research. We propose to develop a novel, flexible, generic, and highly efficient protein and nucleic acid delivery system based upon VP22, a structural protein of the herpes simplex virus 1. VP22 exhibits a unique form of intracellular transfer, whereby it is capable of efficiently exiting the mammalian cell in which it is synthesized, diffusing locally, entering a neighboring cell, and translocating to the recipient cell nucleus. Significantly, fusion proteins between VP22 and a second polypeptide chain retain functional characteristics of both proteins. We propose to develop a specifically modified version of VP22 that will be capable of delivering functional nucleic acid or protein to the nucleus of cells. Our modified VP22 protein will be prepared and incubated in vitro with tagged protein or nucleic acid. Based upon the extremely high affinity between modified VP22 and the tag, modified VP22 will form a tightly bound complex with the tagged macromolecule. Presentation of this complex to naive cells will result in complex uptake and nuclear translocation through the action of VP22; the delivered DNA or protein will retain biological activity. In this Phase I study we will construct, express, and characterize the modified VP22 and demonstrate its ability to efficiently deliver functional DNA and protein into tissue culture cells. Subsequent Phase II research will enhance the system for increased flexibility and explore the use of modified VP22 for the delivery of protein and DNA into tissues of the intact mouse. PROPOSED COMMERCIAL APPLICATION This research is directed towards developing a generalized technology for easily and efficiently introducing functional protein and nucleic acid to the nucleus of living cells. Potential applications include delivery vector for therapeutic intervention, gene therapy, and basic research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RECA/OLIGONUCLEOTIDE-DIRECTED MUTAGENESIS
-
批准号:2421808
-
项目类别:
-
资助金额:$8.9万
-
财政年份:1997
-
负责人:ROBERT A DUBIN
-
依托单位:
海外基金